Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125152616 | 12515261 | 6 | F | 2016 | 20160914 | 20160630 | 20160919 | EXP | US-AMGEN-USASL2016081180 | AMGEN | 72.00 | YR | E | M | Y | 0.00000 | 20160919 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125152616 | 12515261 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 1065293 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 125152616 | 12515261 | 2 | SS | AMOXICILLIN. | AMOXICILLIN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125152616 | 12515261 | 1 | Psoriatic arthropathy |
| 125152616 | 12515261 | 2 | Upper respiratory tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125152616 | 12515261 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125152616 | 12515261 | Abdominal infection | |
| 125152616 | 12515261 | Arthralgia | |
| 125152616 | 12515261 | Candida infection | |
| 125152616 | 12515261 | Chronic kidney disease | |
| 125152616 | 12515261 | Colitis ulcerative | |
| 125152616 | 12515261 | Contusion | |
| 125152616 | 12515261 | Diverticulitis | |
| 125152616 | 12515261 | Gastrointestinal disorder | |
| 125152616 | 12515261 | Gastrointestinal haemorrhage | |
| 125152616 | 12515261 | Gastrointestinal infection | |
| 125152616 | 12515261 | Hot flush | |
| 125152616 | 12515261 | Immunodeficiency common variable | |
| 125152616 | 12515261 | Mobility decreased | |
| 125152616 | 12515261 | Nephrolithiasis | |
| 125152616 | 12515261 | Oropharyngeal pain | |
| 125152616 | 12515261 | Papule | |
| 125152616 | 12515261 | Pyrexia | |
| 125152616 | 12515261 | Sinusitis | |
| 125152616 | 12515261 | Therapeutic response unexpected | |
| 125152616 | 12515261 | Unevaluable event | |
| 125152616 | 12515261 | Upper respiratory tract infection | |
| 125152616 | 12515261 | Vasculitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125152616 | 12515261 | 1 | 20160303 | 0 | ||
| 125152616 | 12515261 | 2 | 201606 | 0 |